Search

Accuray Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

0.27 -12.9

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.28

Max

0.31

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2M

-12M

Pardavimai

2.6M

105M

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-11.259

Darbuotojai

990

EBITDA

2.5M

-813K

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+12.9% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-22M

32M

Ankstesnė atidarymo kaina

13.17

Ankstesnė uždarymo kaina

0.27

Naujienos nuotaikos

By Acuity

50%

50%

175 / 340 reitingas Healthcare

Accuray Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-04 20:02; UTC

Accuray Inc shares are higher today amid positive market sentiment and declining crude oil prices. Comments on potential peace talks with Iran also support the move.

2026-08-03 19:31; UTC

Accuray Inc shares are lower today, with no specific news identified to explain the decline, despite broader market gains.

2026-07-31 23:16; UTC

Accuray Inc shares are lower in after-market trading, with no specific news identified. Broader market pressures also impacted other tech companies, including Apple Inc.

2026-07-30 23:51; UTC

Accuray Inc shares are lower in after-market hours, with no specific news identified for the decline. Broader market conditions remain mixed amid geopolitical concerns.

2026-07-29 23:02; UTC

News

Accuray Inc. announced a $40 million debt exchange and $15 million equity investment to enhance its financial position, with shares trading higher after market close.

2026-07-28 23:16; UTC

Accuray Inc shares are trading lower in after-market hours, reflecting broader market pressures in the technology sector amid concerns over AI spending and competition.

2026-07-27 19:32; UTC

Accuray Inc's shares are declining today, hitting a low after an early high. Broader market conditions, including falling oil prices, may be influencing sentiment.

2026-07-24 19:11; UTC

Accuray Inc's shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains near its one-month low.

2026-07-22 18:51; UTC

Accuray Inc. shares are trading flat, remaining 7.82% below their 20-day moving average amid a lack of upward momentum.

2026-07-20 19:31; UTC

Accuray Inc shares are lower today, diverging from a recent trend of higher closes. Broader market dynamics may be impacting investor sentiment.

Akcijų palyginimas

Kainos pokytis

Accuray Inc Prognozė

Kainos tikslas

By TipRanks

12.9% į viršų

12 mėnesių prognozė

Vidutinis 0.35 USD  12.9%

Aukščiausias 0.35 USD

Žemiausias 0.35 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Accuray Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

175 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Accuray Inc

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
help-icon Live chat